Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × FED × Ototoxicity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Uterine Cervical Dysplasia 1 Ototoxicity 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Health Education 1 Colorectal Neoplasms 1 Bowen's Disease 1

Interventions

Thioctic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00477607 2014-03-07

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

VA Office of Research and Development

Phase 2/3 Completed

39 enrolled 11 charts

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡